OXBOF (Oxford BioDynamics) Inventory Turnover: 1.24 (As of Sep. 2025)


What is Oxford BioDynamics Inventory Turnover?

Oxford BioDynamics OXBOF -33.33% Inventory Turnover is 1.24 as of Sep. 2025. The stock has 4 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Oxford BioDynamics's Cost of Goods Sold for the six months ended in Sep. 2025 was $0.39 Mil. Oxford BioDynamics's Average Total Inventories for the quarter that ended in Sep. 2025 was $0.32 Mil. Oxford BioDynamics's Inventory Turnover for the quarter that ended in Sep. 2025 was 1.24.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Oxford BioDynamics's Days Inventory for the six months ended in Sep. 2025 was 147.53.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Oxford BioDynamics's Inventory-to-Revenue for the quarter that ended in Sep. 2025 was 0.46.


Oxford BioDynamics  (OTCPK:OXBOF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Oxford BioDynamics's Days Inventory for the six months ended in Sep. 2025 is calculated as:

Days Inventory =Average Total Inventories (Q: Sep. 2025 )/Cost of Goods Sold (Q: Sep. 2025 )*Days in Period
=0.3185/0.394*365 / 2
=147.53

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Oxford BioDynamics's Inventory to Revenue for the quarter that ended in Sep. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Sep. 2025 ) / Revenue (Q: Sep. 2025 )
=0.3185 / 0.686
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


Oxford BioDynamics Inventory Turnover Related Terms


Oxford BioDynamics Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Oxford BioDynamics's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford BioDynamics Inventory Turnover Chart

Oxford BioDynamics Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.09 0.84 1.20 2.25

Oxford BioDynamics Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.53 0.78 0.57 0.91 1.24

Oxford BioDynamics Inventory Turnover Calculation

Oxford BioDynamics's Inventory Turnover for the fiscal year that ended in Sep. 2025 is calculated as

Inventory Turnover (A: Sep. 2025 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Sep. 2025 ) / ((Total Inventories (A: Sep. 2024 ) + Total Inventories (A: Sep. 2025 )) / count )
=0.775 / ((0.425 + 0.264) / 2 )
=0.775 / 0.3445
=2.25

Oxford BioDynamics's Inventory Turnover for the quarter that ended in Sep. 2025 is calculated as

Inventory Turnover (Q: Sep. 2025 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Sep. 2025 ) / ((Total Inventories (Q: Mar. 2025 ) + Total Inventories (Q: Sep. 2025 )) / count )
=0.394 / ((0.373 + 0.264) / 2 )
=0.394 / 0.3185
=1.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Inventory Turnover →
What does a Inventory Turnover of 1.24 mean?
Oxford BioDynamics (OXBOF) has a Inventory Turnover of 1.24 as of Sep. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Oxford BioDynamics and its competitors.
Is Oxford BioDynamics' Inventory Turnover too high?
Oxford BioDynamics' current Inventory Turnover is 1.24.
How does Oxford BioDynamics' Inventory Turnover compare to TMO and DHR?
Oxford BioDynamics' Inventory Turnover of 1.24 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventory Turnover for a Medical Diagnostics & Research company?
A good Inventory Turnover depends on the Medical Diagnostics & Research industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventory Turnover mean?
A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Oxford BioDynamics and its competitors. Oxford BioDynamics's current Inventory Turnover is 1.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford BioDynamics stock overvalued right now?
Based on GuruFocus' analysis, Oxford BioDynamics (OXBOF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.06, compared to a current price of $0.00 — trading 96.7% below its estimated fair value. The current Inventory Turnover is 1.24. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventory Turnover calculated?
Inventory Turnover is calculated from a company's financial statements. For Oxford BioDynamics (OXBOF), the current Inventory Turnover is 1.24 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oxford BioDynamics Business Description

Other Exchanges OBD:UKLMQ:Germany
Address John Smith Drive, 3140 Rowan Place, Oxford Business Park South, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company focused on advancing personalized healthcare through the development and commercialization of precision medicine tests for serious and impactful diseases. The company is engaged in the commercialisation of proprietary molecular diagnostics products and biomarker research and development. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The company generates revenue from the sales of proprietary products and biomarker research and development. Geographically, it generates the maximum revenue from the USA.